Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice

Ankylosing spondylitis is a chronic, progressive disease, and its treatment is relevant to the gut microbiota. Anti‐tumor necrosis factor‐alpha (anti‐TNF‐α) therapy alters the gut microbiota in many diseases, including inflammatory bowel disease. However, little is known about the effect of TNF‐α bl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Microbiologyopen
Autores principales: Liu, Bin, Yang, Lianjun, Cui, Zhifei, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Su, Zhihai, Wang, Min, Zhang, Weicong, Liu, Jinshi, Wang, Tingxuan, Li, Qingchu, Lu, Hai
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6925169/
https://ncbi.nlm.nih.gov/pubmed/31556231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mbo3.927
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares